-
Mashup Score: 1Cancer - 9 month(s) ago
Please check your email for instructions on resetting your password. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new Wiley Online Library account. Can’t sign in? Forgot your username?
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Cancer : Author Guidelines - 9 month(s) ago
Please check your email for instructions on resetting your password. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new Wiley Online Library account. Can’t sign in? Forgot your username?
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2American Cancer Society National HPV Vaccination Roundtable on LinkedIn: HPV vaccination starts at age 9. The CDC, the American Academy of… - 9 month(s) ago
HPV vaccination starts at age 9. The CDC, the American Academy of Pediatrics (AAP), the American Cancer Society, and the National HPV Vaccination Roundtable…
Source: www.linkedin.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 4ESMO E-Learning and V-Learning | OncologyPRO - 9 month(s) ago
ESMO E-Learning: Prognostic and Predictive Biomarkers in Head and Neck Cancer
Source: oncologypro.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2The CCDI Comes Out of the Starting Block - 9 month(s) ago
The Children’s Cancer Data Initiative is investing $500 million US dollars over 10 years to improve current treatments for cancers arising in pediatric, adolescent, and young adult patients by supporting research that will result in new therapies to improve overall cure rates while reducing the devastating adverse long-term health outcomes for survivors. In the article that accompanies this editorial, Flores-Toro et al 3 describe the origins of the Childhood Cancer Data Initiative, provide an interim
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Science Talk - “Immunotherapy is keeping me alive” - John’s story - - 10 month(s) ago
On his daughter’s second birthday in 2009, John Dabell was diagnosed with advanced head and neck cancer. He went through extensive surgery and treatment and was on the road to recovery when he was diagnosed with cancer again – this time, a tumour in his throat. John was told he didn’t have long to live. But then he started immunotherapy. Here, he talks about its incredible impact and the opportunity it’s given him to spend more time with his wife and daughter.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Telephone Intervention Improves Care Management in Radiotherapy for HNC - 10 month(s) ago
A quality improvement project sought to improve pain management in patients undergoing radiation therapy for head and neck cancer.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Drug Shortages - 10 month(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Role of Chemotherapy in Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Radiotherapy - The ASCO Post - 10 month(s) ago
By Matthew Stenger Posted: 6/26/2023 9:26:00 AM Last Updated: 6/26/2023 9:11:29 AM In an updated individual patient data network meta-analysis reported in The Lancet Oncology, Petit et al found that the treatment approach with the highest overall survival benefit among patients with nonmetastatic…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Adjuvant Gemcitabine-Cisplatin Improves PFS in Nasopharyngeal Carcinoma - 10 month(s) ago
Gemcitabine plus cisplatin provides benefits over 5-fluorouracil plus cisplatin as adjuvant treatment for nasopharyngeal carcinoma, phase 3 data suggest.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Submit your research today! @JournalCancer is accepting early, promising findings in #HeadAndNeckCancer treatment. Learn about the benefits of publishing in Cancer here: https://t.co/zGZDIYWSEN @ACS_Research https://t.co/yJip4Jl0sW